| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 10% | 658,465 | Ayrton Capital LLC | 30 Sep 2025 | ||||
| Lind Global Fund III LP | 10% | $552,346 | 141,265 | Lind Global Fund III LP | 28 Jan 2026 | |||
| INTRACOASTAL CAPITAL, LLC | 5% | 0% | $278,572 | +$155,982 | 71,246 | +127% | Mitchell P. Kopin | 27 Jan 2026 |
As of 31 Dec 2025, 11 institutional investors reported holding 24,171 shares of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB). This represents 1.7% of the company’s total 1,414,064 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 24,171 | $87,744 | +$87,744 | $3.63 | 11 |